Literature DB >> 15755626

Surveillance system of vaccine adverse events and local data analysis--the experience in a middle-sized city in Brazil, 1999-2001.

Guilherme Côrtes Fernandes1, Luiz Antonio Bastos Camacho, Marilia Sá Carvalho.   

Abstract

We reviewed all vaccine adverse events (VAE) notified in a middle-sized Brazilian city (n=247) to the National Immunisation Program between January 1999 and December 2001. Vaccine doses used in that period were considered for rate estimates. Aspects of the surveillance system (SS) and their influences on collected data were considered, searching for contributions of local data analysis to investigation of VAE and to the monitoring of vaccine safety. Notification rates in our study were higher when compared to national data. Changes in the notification pattern were observed following vaccination campaign periods. An increase in aseptic meningitis cases temporally associated to yellow fever vaccine was detected. The analysis of local data provided information unperceived in national consolidated data. Through this analysis we detected: events related to application technique and handling; people's perception changes on VAE; and the local SS's ability to raise new hypothesis. We suggested changes to the notification form regarding data entry criteria and analysis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15755626     DOI: 10.1016/j.vaccine.2005.01.022

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  2 in total

1.  Adverse Events of Vaccination against Hepatitis B Virus in Post-Marketing Surveillance from 2005 to 2017 in Guangdong Province, China.

Authors:  Yu Liu; Minyi Zhang; Meiling Yang; Qing Chen
Journal:  Vaccines (Basel)       Date:  2022-07-06

2.  Use of electronic immunization registry in the surveillance of adverse events following immunization.

Authors:  Ana Paula Sayuri Sato; Vinícius Leati de Rossi Ferreira; Márcia de Cantuária Tauil; Laura Cunha Rodrigues; Mariana Bernardes Barros; Edmar Martineli; Ângela Aparecida Costa; Marta Inenami; Eliseu Alves Waldman
Journal:  Rev Saude Publica       Date:  2018-02-05       Impact factor: 2.106

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.